Resmed Inc. (RMD) gains 0.05% for July 21

Equities Staff  |

Resmed Inc. (NYSE: RMD) shares gained 0.05%, or $0.12 per share, to close Wednesday at $255.37. After opening the day at $255.46, shares of Resmed fluctuated between $255.54 and $252.08. 298,029 shares traded hands a decrease from their 30 day average of 567,617. Wednesday's activity brought Resmed’s market cap to $37,160,888,758.

Resmed is headquartered in San Diego, California..

About Resmed Inc.

ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.

Visit Resmed Inc.’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Resmed Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: Resmed Inc.’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content